Welcome to LookChem.com Sign In|Join Free
  • or
Z-3-aminobutyric acid, also known as β-3-aminobutyric acid, is an organic compound with the molecular formula C4H9NO2, classified as an amino acid derivative. It is a derivative of the neurotransmitter γ-aminobutyric acid (GABA) and plays a crucial role in the metabolism and biosynthesis of GABA in the brain and central nervous system. This chemical is believed to have potential therapeutic applications in the treatment of anxiety, depression, and other neurological disorders, making it an important chemical with various potential applications in medicine and industry.

51440-81-4

Post Buying Request

51440-81-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51440-81-4 Usage

Uses

Used in Pharmaceutical Industry:
Z-3-aminobutyric acid is used as a building block for the synthesis of pharmaceuticals and biologically active compounds. Its role in the metabolism and biosynthesis of GABA makes it a valuable component in the development of new drugs targeting neurological disorders.
Used in Neurological Disorder Treatment:
Z-3-aminobutyric acid is used as a therapeutic agent for the treatment of anxiety, depression, and other neurological disorders. Its involvement in the GABAergic system suggests potential benefits in modulating neurotransmission and alleviating symptoms associated with these conditions.
Used in Research and Development:
Z-3-aminobutyric acid is utilized in research and development for understanding the role of GABA in the brain and central nervous system. Its potential applications in medicine and industry make it an essential compound for exploring new therapeutic approaches and drug development strategies.

Check Digit Verification of cas no

The CAS Registry Mumber 51440-81-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,4,4 and 0 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 51440-81:
(7*5)+(6*1)+(5*4)+(4*4)+(3*0)+(2*8)+(1*1)=94
94 % 10 = 4
So 51440-81-4 is a valid CAS Registry Number.

51440-81-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (39599)  Z-DL-β-Homoalanine  ≥98.0% (HPLC)

  • 51440-81-4

  • 39599-1G

  • 932.49CNY

  • Detail

51440-81-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(phenylmethoxycarbonylamino)butanoic acid

1.2 Other means of identification

Product number -
Other names Z-3-Aminobutyric acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51440-81-4 SDS

51440-81-4Relevant academic research and scientific papers

The kinetic resolution of oxazinones by alcoholysis: access to orthogonally protected β-amino acids

Connon, Stephen J.,Cronin, Sarah A.

supporting information, p. 7348 - 7352 (2021/09/07)

The catalytic, alcoholytic kinetic resolution of oxazinones is reported. A novel, stereochemically dense cinchona alkaloid-based catalyst can facilitate the highly enantiodiscriminatory (Sup to 101) ring-opening of oxazinones equipped with electrophilic aryl units to generate orthogonally protected β-amino acids for the first time.

Trimethyl-substituted carbamate as a versatile self-immolative linker for fluorescence detection of enzyme reactions

Inoue, Kazuya,Nakamura, Noriaki,Ojida, Akio,Uchinomiya, Shohei

supporting information, (2020/05/25)

Self-immolative linker is a useful building block of molecular probes, with broad applications in the fields of enzyme activity analysis, stimuli-responsive material science, and drug delivery. This manuscript presents N-methyl dimethyl methyl (i.e., trimethyl) carbamate as a new class of self-immolative linker for the fluorescence detection of enzyme reactions. The trimethyl carbamate was shown to spontaneously undergo intramolecular cyclization upon formation of a carboxylate group, to liberate a fluorophore with the second time rapid reaction kinetics. Interestingly, the auto-cleavage reaction of trimethyl carbamate was also induced by the formation of hydroxyl and amino groups. Fluorescent probes with a trimethyl carbamate could be applicable for fluorescence monitoring of the enzyme reactions catalyzed by esterase, ketoreductase, and aminotransferase, and for fluorescence imaging of intracellular esterase activity in living cells, hence demonstrating the utility of this new class of self-immolative linker.

ARYL SULTAM DERIVATIVES AS RORc MODULATORS

-

Page/Page column 40, (2017/01/26)

Compounds of the formula I: or a pharmaceutical salt thereof, wherein p, s, A, R3 and Re are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

ARYL SULTAM DERIVATIVES AS RORc MODULATORS

-

Page/Page column 69-70, (2017/01/26)

Compounds of the formula I, or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, X1, X2, X3, X4, Y, Z, A, Het, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein.. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis, muscular sclerosis and psoriasis.

HETEROARYL AMIDE SULTAM DERIVATIVES AS RORc MODULATORS

-

Page/Page column 45; 46, (2017/07/06)

Compounds of the formula I: (I) or a pharmaceutical salt thereof, wherein m, n, p, q, Het, A, W, R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

ARYL SULTAM DERIVATIVES AS RORc MODULATORS

-

Paragraph 1210; 1211, (2016/07/05)

Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, A, W, X1, X2, X3, X4, Y, Z, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

HETEROARYLALKYLENE ARYL SULTAM DERIVATIVES AS RORc MODULATORS

-

Page/Page column 42, (2016/07/05)

Compounds of the formula (I): or a pharmaceutical salt thereof, wherein m, n, p, q, Het, A, W, R1, R2, R3, R4, R5, R6, R7, R8, R and R10are as defined herein are modulators of retinoid-receptor related orphan receptor RORc (RORy). Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

Synthesis of Substituted Quinolizidines via a Gold-Catalyzed Double Cyclization Cascade

Nonaka, Shiori,Sugimoto, Kenji,Ueda, Hirofumi,Tokuyama, Hidetoshi

supporting information, p. 380 - 385 (2016/02/12)

A novel synthesis of quinolizidines by a cationic gold-catalyzed double cyclization cascade has been developed. The reaction was initiated by the gold-catalyzed 6-exo-dig cyclization of ynamides, which was followed by a second cyclization of an enamide intermediate to provide the corresponding quinolizidine derivatives. The utility of this reaction was demonstrated by application to the synthesis of multi-substituted quinolizidines and by the total synthesis of a quinolizidine alkaloid, (±)-lupinine.

ARYL SULTAM DERIVATIVES AS RORc MODULATORS

-

Paragraph 1201; 1202, (2015/07/22)

Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, A, W, X1, X2, X3, X4, Y, Z, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

IOP-lowering effect of isoquinoline-5-sulfonamide compounds in ocular normotensive monkeys

Sumi, Kengo,Inoue, Yoshihiro,Nishio, Masahiro,Naito, Yasuhito,Hosoya, Takamitsu,Suzuki, Masaaki,Hidaka, Hiroyoshi

, p. 831 - 834 (2014/02/14)

Rho-associated coiled coil-formed protein kinase (ROCK) inhibitors are under development as a new class of antiglaucoma agents. Based on the potent ROCK inhibitor H-1152, previously developed by us, we explored the possibility of related compounds as anti

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 51440-81-4